Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ADUS NASDAQ:AMED NYSE:CHE On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeADUSAddus HomeCare$97.29+0.7%$97.85$90.89▼$124.43$1.80B0.92266,016 shs318,419 shsAMEDAmedisys$101.01+0.0%$99.72$92.44▼$101.02$3.32B0.89509,062 shs1.06 million shsCHEChemed$425.39+0.2%$396.39$365.20▼$583.96$5.64B0.54265,912 shs219,157 shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceADUSAddus HomeCare+0.67%+0.41%+4.44%-8.11%-13.33%AMEDAmedisys0.00%0.00%0.00%0.00%+5.01%CHEChemed+0.07%+0.04%+9.50%-4.95%-26.31%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeADUSAddus HomeCare$97.29+0.7%$97.85$90.89▼$124.43$1.80B0.92266,016 shs318,419 shsAMEDAmedisys$101.01+0.0%$99.72$92.44▼$101.02$3.32B0.89509,062 shs1.06 million shsCHEChemed$425.39+0.2%$396.39$365.20▼$583.96$5.64B0.54265,912 shs219,157 shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceADUSAddus HomeCare+0.67%+0.41%+4.44%-8.11%-13.33%AMEDAmedisys0.00%0.00%0.00%0.00%+5.01%CHEChemed+0.07%+0.04%+9.50%-4.95%-26.31%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceADUSAddus HomeCare 2.73Moderate Buy$132.3336.02% UpsideAMEDAmedisys 0.00N/AN/AN/ACHEChemed 2.33Hold$501.5017.89% UpsideCurrent Analyst Ratings BreakdownLatest CHE, AMED, and ADUS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/6/2026ADUSAddus HomeCare Citizens JmpSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetMarket Outperform$150.00 ➝ $142.004/29/2026CHEChemed Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (D+) ➝ Hold (C-)4/27/2026CHEChemed Royal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetSector Perform$422.00 ➝ $436.004/27/2026CHEChemed Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong Sell ➝ Hold4/13/2026CHEChemed Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold (C-) ➝ Sell (D+)3/25/2026ADUSAddus HomeCare BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetUnderweight$112.00 ➝ $102.003/4/2026CHEChemed Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold ➝ Strong Sell2/27/2026CHEChemed OppenheimerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOutperform$580.00 ➝ $500.002/27/2026CHEChemed Royal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform ➝ Sector Perform$572.00 ➝ $422.002/25/2026ADUSAddus HomeCare Royal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform$139.002/25/2026ADUSAddus HomeCare KeyCorpSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOverweight(Data available from 5/8/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookADUSAddus HomeCare$1.42B1.28$6.54 per share14.88$59.80 per share1.63AMEDAmedisys$2.40B1.38$6.24 per share16.20$38.77 per share2.61CHEChemed$2.53B2.23$24.72 per share17.21$63.88 per share6.66Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateADUSAddus HomeCare$95.91M$5.2117.9814.501.336.89%9.80%7.34%N/AAMEDAmedisys$43.23M$2.5739.3020.871.343.56%12.91%7.29%N/ACHEChemed$265.24M$18.3523.1816.701.5910.23%27.18%17.38%N/ALatest CHE, AMED, and ADUS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/4/2026Q1 2026ADUSAddus HomeCare$1.52$1.62+$0.10$1.36$366.41 million$363.50 million4/23/2026Q1 2026CHEChemed$5.30$5.65+$0.35$4.84$659.22 million$657.51 million2/25/2026Q4 2025CHEChemed$7.02$6.42-$0.60$5.48$659.09 million$639.34 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthADUSAddus HomeCareN/AN/AN/AN/AN/AAMEDAmedisysN/AN/AN/AN/AN/ACHEChemed$2.400.56%+10.76%13.08%16 YearsLatest CHE, AMED, and ADUS DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date2/13/2026CHEChemedquarterly$0.600.5%2/23/20262/23/20263/13/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioADUSAddus HomeCare0.081.831.80AMEDAmedisys0.261.361.36CHEChemed0.110.850.83Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipADUSAddus HomeCare95.35%AMEDAmedisys94.36%CHEChemed95.85%Insider OwnershipCompanyInsider OwnershipADUSAddus HomeCare4.50%AMEDAmedisys2.10%CHEChemed3.33%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableADUSAddus HomeCare50,65918.67 million17.83 millionOptionableAMEDAmedisys20,00032.89 million32.20 millionOptionableCHEChemed15,81113.27 million12.83 millionOptionableCHE, AMED, and ADUS HeadlinesRecent News About These CompaniesChemed Corporation $CHE Shares Acquired by UBS Group AGMay 6 at 8:25 AM | marketbeat.comHarel Insurance Investments & Financial Services Ltd. Purchases 10,635 Shares of Chemed Corporation $CHEMay 6 at 4:34 AM | marketbeat.comChemed Corporation to Present at the Bank of America Securities Health Care Conference 2026May 5 at 9:00 AM | globenewswire.comVan Berkom & Associates Inc. Acquires 4,056 Shares of Chemed Corporation $CHEMay 5 at 8:49 AM | marketbeat.comChemed Corporation $CHE Shares Acquired by Mitsubishi UFJ Trust & Banking CorpMay 5 at 5:21 AM | marketbeat.comInsider Selling: Chemed (NYSE:CHE) CEO Sells $842,260.00 in StockMay 5 at 4:35 AM | insidertrades.comWhen Two Temporary Disruptions Get Priced as Permanent at ChemedMay 4, 2026 | finance.yahoo.comInsider Selling: Chemed (NYSE:CHE) CEO Sells 2,000 Shares of StockMay 4, 2026 | marketbeat.comChemed Corporation $CHE Position Trimmed by Vanguard Group Inc.May 4, 2026 | marketbeat.comChemed (NYSE:CHE) Stock Rating Upgraded by Wall Street ZenMay 2, 2026 | marketbeat.comChemed (NYSE:CHE) Raised to Hold at Zacks ResearchApril 29, 2026 | marketbeat.comA Look At Chemed (CHE) Valuation After Earnings Beat And VITAS Margin StrengthApril 28, 2026 | finance.yahoo.comChemed Corporation Shines in Q1 2026 with Strong VITAS Healthcare PerformanceApril 27, 2026 | news.themarketisopen.comNChemed Q1 Earnings Call HighlightsApril 27, 2026 | marketbeat.comCHE Stock Up Following Q1 Earnings & Revenue Beat, Margins DownApril 27, 2026 | zacks.comChemed Corporation $CHE Shares Bought by Cwm LLCApril 26, 2026 | defenseworld.netDAbacus FCF Advisors LLC Acquires New Holdings in Chemed Corporation $CHEApril 26, 2026 | marketbeat.comChemed lifts 2026 outlook as HCA holds guidance after mixed Q1April 25, 2026 | msn.comChemed Corp (CHE) Q1 2026 Earnings Call Highlights: Strong VITAS Performance Amid Roto-Rooter ...April 25, 2026 | finance.yahoo.comCHE Q1 Deep Dive: VITAS Drives Growth, Roto-Rooter Adapts to Higher Marketing CostsApril 25, 2026 | finance.yahoo.comImpax Asset Management Group plc Trims Position in Chemed Corporation $CHEApril 25, 2026 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All Headlines3 Dividend Aristocrats Whose Yields Can Help Combat InflationBy Chris Markoch | April 9, 2026NVIDIA's Quantum Computing Play Just Sent IonQ and Rigetti Flying By Jeffrey Neal Johnson | April 15, 2026The Real SpaceX Play: 5 Chip Stocks Powering the IPO Before It LaunchesBy Bridget Bennett | May 4, 2026AI, Satellites and Staples: Insiders Are Buying and Selling 3 Big NamesBy Leo Miller | April 13, 2026This 4/20, Wall Street Is Betting on More Than MarijuanaBy Jeffrey Neal Johnson | April 20, 2026CHE, AMED, and ADUS Company DescriptionsAddus HomeCare NASDAQ:ADUS$97.29 +0.65 (+0.67%) Closing price 05/7/2026 04:00 PM EasternExtended Trading$97.29 +0.00 (+0.00%) As of 04:08 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas.Amedisys NASDAQ:AMEDAmedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.Chemed NYSE:CHE$425.39 +0.83 (+0.20%) Closing price 05/7/2026 03:59 PM EasternExtended Trading$425.74 +0.35 (+0.08%) As of 05/7/2026 05:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas The AI Fear Around Datadog Stock May Have Been Completely Wrong Amprius Technologies Ups the Voltage on Forward Outlook Why Lam Research Still Looks Like a Buy After a 300% Rally IonQ Just Posted a Breakout Quarter—But 1 Problem Remains Super Micro Surges Over 20% as Margins Soar, Sales Fall Short Nuts and Bolts AI Play Gains Momentum: Astera Labs Targets Raised Anheuser-Busch Stock Jumps as Volume Growth Signals Turnaround Light Speed Returns: Corning Cashes In on NVIDIA Growth Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
